|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q53977424
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010719.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q53977424
|
|
024
|
|
|
‡a
0000-0002-6978-8989
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q53977424
|
|
100
|
0 |
|
‡a
Ana Macedo
‡c
researcher (ORCID 0000-0002-6978-8989)
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Ana Macedo
‡c
onderzoeker
‡9
nl
|
|
670
|
|
|
‡a
Author's A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials.
|
|
670
|
|
|
‡a
Author's A study of bone density change in patients with anorexia nervosa
|
|
670
|
|
|
‡a
Author's Are women and men well informed about fertility? Childbearing intentions, fertility knowledge and information-gathering sources in Portugal
|
|
670
|
|
|
‡a
Author's [Assessment of an obesity clinic in a center hospital]
|
|
670
|
|
|
‡a
Author's Cardiovascular risk factors -- from the mathematical formula to clinical practice
|
|
670
|
|
|
‡a
Author's [Characterization of leukocytes, lymphocytes and lymphocyte subsets in eating disorders]
|
|
670
|
|
|
‡a
Author's [Characterization of oncological disease: racional, objectives and methodology - perfil study]
|
|
670
|
|
|
‡a
Author's [Cost-effectiveness of samarium-153-EDTMP for the treatment of pain due to multiple bone metastases in hormone-refractory prostate cancer versus conventional pain therapy, in Portugal].
|
|
670
|
|
|
‡a
Author's Economic evaluation of capecitabine use as first line treatment in patients with advanced gastric carcinoma in Portugal
|
|
670
|
|
|
‡a
Author's [Estimating the microcosts of blood transfusion for hemato-oncological patients]
|
|
670
|
|
|
‡a
Author's Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry
|
|
670
|
|
|
‡a
Author's [Evaluation of prevalence of individuals with weight excess by region. Study of a young males cohort (1999)]
|
|
670
|
|
|
‡a
Author's Ferric Carboxymaltose in the treatment of chemotherapy-induced anaemia: an effective, safe and cost- sparing alternative to blood transfusion
|
|
670
|
|
|
‡a
Author's Gla-Rich Protein (GRP) as an Early and Novel Marker of Vascular Calcification and Kidney Dysfunction in Diabetic Patients with CKD: A Pilot Cross-Sectional Study
|
|
670
|
|
|
‡a
Author's [Grave's disease and stress]
|
|
670
|
|
|
‡a
Author's Guidelines for prevention of febrile neutropenia
|
|
670
|
|
|
‡a
Author's [Hyperthyroidism in a hospital environment: 5-year evaluation]
|
|
670
|
|
|
‡a
Author's Incremental cost evaluation study of INR self-monitoring versus laboratorial control or monitoring in health care centres, in Portugal
|
|
670
|
|
|
‡a
Author's [Influence of placebo effect on planning and analysis of clinical trials]
|
|
670
|
|
|
‡a
Author's Pirlindole in the treatment of depression: a meta-analysis.
|
|
670
|
|
|
‡a
Author's Placebo response in the prophylaxis of migraine: a meta-analysis.
|
|
670
|
|
|
‡a
Author's Prevalence and distribution of the main cardiovascular risk factors in Portugal--the AMALIA study
|
|
670
|
|
|
‡a
Author's Prevalence of paroxysmal atrial fibrillation in a population assessed by continuous 24-hour monitoring.
|
|
670
|
|
|
‡a
Author's [Prevalence of type 1 diabetes mellitus in Portugal, 1995-1999: cohort of young men].
|
|
670
|
|
|
‡a
Author's [Secular trends of weight in Portugal at the end of the 20th century].
|
|
670
|
|
|
‡a
Author's Self-reported cerebrovascular and heart diseases and cardiovascular risk factors in Portugal: the AMALIA study.
|
|
670
|
|
|
‡a
Author's Serum Lipoprotein Profile Is Associated With Protective Effects of Oral Contraceptive Use on Multiple Sclerosis Severity: A Cross-Sectional Study
|
|
670
|
|
|
‡a
Author's STING Study: STudy on Individual perceptioN, knowledGe and characterization of neuropathic pain, in Portugal - Community data
|
|
670
|
|
|
‡a
Author's The relationship between body mass index and educational level in young Portuguese males: 1995 and 1999 cohorts
|
|
670
|
|
|
‡a
Author's Trends of weight, height and obesity in young Portuguese males: 1995-1999.
|
|
909
|
|
|
‡a
(orcid) 0000000269788989
‡9
1
|
|
919
|
|
|
‡a
prevalenceanddistributionofthemaincardiovascularriskfactorsinportugaltheamaliastudy
‡A
Prevalence and distribution of the main cardiovascular risk factors in Portugal--the AMALIA study
‡9
1
|
|
919
|
|
|
‡a
prevalenceoftype1diabetesmellitusinportugal19951999cohortofyoungmen
‡A
[Prevalence of type 1 diabetes mellitus in Portugal, 1995-1999: cohort of young men].
‡9
1
|
|
919
|
|
|
‡a
seculartrendsofweightinportugalattheendofthe20century
‡A
[Secular trends of weight in Portugal at the end of the 20th century].
‡9
1
|
|
919
|
|
|
‡a
selfreportedcerebrovascularandheartdiseasesandcardiovascularriskfactorsinportugaltheamaliastudy
‡A
Self-reported cerebrovascular and heart diseases and cardiovascular risk factors in Portugal: the AMALIA study.
‡9
1
|
|
919
|
|
|
‡a
serumlipoproteinprofileisassociatedwithprotectiveeffectsoforalcontraceptiveuseonmultiplesclerosisseverityacrosssectionalstudy
‡A
Serum Lipoprotein Profile Is Associated With Protective Effects of Oral Contraceptive Use on Multiple Sclerosis Severity: A Cross-Sectional Study
‡9
1
|
|
919
|
|
|
‡a
stingstudystudyonindividualperceptionknowledgeandcharacterizationofneuropathicpaininportugalcommunitydata
‡A
STING Study: STudy on Individual perceptioN, knowledGe and characterization of neuropathic pain, in Portugal - Community data
‡9
1
|
|
919
|
|
|
‡a
relationshipbetweenbodymassindexandeducationallevelinyoungportuguesemales1995and1999cohorts
‡A
The relationship between body mass index and educational level in young Portuguese males: 1995 and 1999 cohorts
‡9
1
|
|
919
|
|
|
‡a
trendsofweightheightandobesityinyoungportuguesemales1995
‡A
Trends of weight, height and obesity in young Portuguese males: 1995-1999.
‡9
1
|
|
919
|
|
|
‡a
metaanalysisoftheplaceboresponseinacutemigraineandhowthisresponsemaybeinfluencedbysomeofthecharacteristicsofclinicaltrials
‡A
A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials.
‡9
1
|
|
919
|
|
|
‡a
glarichproteingrpasanearlyandnovelmarkerofvascularcalcificationandkidneydysfunctionindiabeticpatientswithckdapilotcrosssectionalstudy
‡A
Gla-Rich Protein (GRP) as an Early and Novel Marker of Vascular Calcification and Kidney Dysfunction in Diabetic Patients with CKD: A Pilot Cross-Sectional Study
‡9
1
|
|
919
|
|
|
‡a
ferriccarboxymaltoseinthetreatmentofchemotherapyinducedanaemiaaneffectivesafeandcostsparingalternativetobloodtransfusion
‡A
Ferric Carboxymaltose in the treatment of chemotherapy-induced anaemia: an effective, safe and cost- sparing alternative to blood transfusion
‡9
1
|
|
919
|
|
|
‡a
evaluationofprevalenceofindividualswithweightexcessbyregionstudyofayoungmalescohort
‡A
[Evaluation of prevalence of individuals with weight excess by region. Study of a young males cohort (1999)]
‡9
1
|
|
919
|
|
|
‡a
evaluationofboneremodelinginhemodialysispatientsserumbiochemistrycirculatingcytokinesandbonehistomorphometry
‡A
Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry
‡9
1
|
|
919
|
|
|
‡a
prevalenceofparoxysmalatrialfibrillationinapopulationassessedbycontinuous24hourmonitoring
‡A
Prevalence of paroxysmal atrial fibrillation in a population assessed by continuous 24-hour monitoring.
‡9
1
|
|
919
|
|
|
‡a
estimatingthemicrocostsofbloodtransfusionforhematooncologicalpatients
‡A
[Estimating the microcosts of blood transfusion for hemato-oncological patients]
‡9
1
|
|
919
|
|
|
‡a
economicevaluationofcapecitabineuseas1linetreatmentinpatientswithadvancedgastriccarcinomainportugal
‡A
Economic evaluation of capecitabine use as first line treatment in patients with advanced gastric carcinoma in Portugal
‡9
1
|
|
919
|
|
|
‡a
costeffectivenessofsamarium153edtmpforthetreatmentofpainduetomultiplebonemetastasesinhormonerefractoryprostatecancerversusconventionalpaintherapyinportugal
‡A
[Cost-effectiveness of samarium-153-EDTMP for the treatment of pain due to multiple bone metastases in hormone-refractory prostate cancer versus conventional pain therapy, in Portugal].
‡9
1
|
|
919
|
|
|
‡a
characterizationofoncologicaldiseaseracionalobjectivesandmethodologyperfilstudy
‡A
[Characterization of oncological disease: racional, objectives and methodology - perfil study]
‡9
1
|
|
919
|
|
|
‡a
characterizationofleukocyteslymphocytesandlymphocytesubsetsineatingdisorders
‡A
[Characterization of leukocytes, lymphocytes and lymphocyte subsets in eating disorders]
‡9
1
|
|
919
|
|
|
‡a
cardiovascularriskfactorsfromthemathematicalformulatoclinicalpractice
‡A
Cardiovascular risk factors -- from the mathematical formula to clinical practice
‡9
1
|
|
919
|
|
|
‡a
assessmentofanobesityclinicinacenterhospital
‡A
[Assessment of an obesity clinic in a center hospital]
‡9
1
|
|
919
|
|
|
‡a
arewomenandmenwellinformedaboutfertilitychildbearingintentionsfertilityknowledgeandinformationgatheringsourcesinportugal
‡A
Are women and men well informed about fertility? Childbearing intentions, fertility knowledge and information-gathering sources in Portugal
‡9
1
|
|
919
|
|
|
‡a
studyofbonedensitychangeinpatientswithanorexianervosa
‡A
A study of bone density change in patients with anorexia nervosa
‡9
1
|
|
919
|
|
|
‡a
gravesdiseaseandstress
‡A
[Grave's disease and stress]
‡9
1
|
|
919
|
|
|
‡a
guidelinesforpreventionoffebrileneutropenia
‡A
Guidelines for prevention of febrile neutropenia
‡9
1
|
|
919
|
|
|
‡a
hyperthyroidisminahospitalenvironment5yearevaluation
‡A
[Hyperthyroidism in a hospital environment: 5-year evaluation]
‡9
1
|
|
919
|
|
|
‡a
incrementalcostevaluationstudyofinrselfmonitoringversuslaboratorialcontrolormonitoringinhealthcarecentresinportugal
‡A
Incremental cost evaluation study of INR self-monitoring versus laboratorial control or monitoring in health care centres, in Portugal
‡9
1
|
|
919
|
|
|
‡a
influenceofplaceboeffectonplanningandanalysisofclinicaltrials
‡A
[Influence of placebo effect on planning and analysis of clinical trials]
‡9
1
|
|
919
|
|
|
‡a
pirlindoleinthetreatmentofdepressionametaanalysis
‡A
Pirlindole in the treatment of depression: a meta-analysis.
‡9
1
|
|
919
|
|
|
‡a
placeboresponseintheprophylaxisofmigraineametaanalysis
‡A
Placebo response in the prophylaxis of migraine: a meta-analysis.
‡9
1
|
|
943
|
|
|
‡a
199x
‡A
1999
‡9
2
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
BLBNB|000275585
|
|
996
|
|
|
‡2
PTBNP|1464698
|
|
996
|
|
|
‡2
ISNI|0000000068378190
|
|
996
|
|
|
‡2
ISNI|0000000069310710
|
|
996
|
|
|
‡2
PTBNP|59859
|
|
996
|
|
|
‡2
PTBNP|59852
|
|
996
|
|
|
‡2
SUDOC|161762670
|
|
996
|
|
|
‡2
PTBNP|251380
|
|
996
|
|
|
‡2
ISNI|000000006932176X
|
|
996
|
|
|
‡2
BIBSYS|90117628
|
|
996
|
|
|
‡2
PTBNP|1631728
|
|
996
|
|
|
‡2
ISNI|0000000070901593
|
|
996
|
|
|
‡2
SUDOC|250285878
|
|
996
|
|
|
‡2
PTBNP|1088467
|
|
996
|
|
|
‡2
LC|no2016154607
|
|
996
|
|
|
‡2
DNB|105709966X
|
|
996
|
|
|
‡2
ISNI|0000000068491177
|
|
996
|
|
|
‡2
BLBNB|000325646
|
|
996
|
|
|
‡2
ISNI|0000000078034586
|
|
996
|
|
|
‡2
NUKAT|n 2022061712
|
|
996
|
|
|
‡2
BLBNB|001459099
|
|
996
|
|
|
‡2
PTBNP|1363337
|
|
996
|
|
|
‡2
LC|n 2017251256
|
|
996
|
|
|
‡2
BNF|17732515
|
|
996
|
|
|
‡2
DNB|1133585302
|
|
996
|
|
|
‡2
ISNI|0000000428141673
|
|
996
|
|
|
‡2
SUDOC|029683289
|
|
996
|
|
|
‡2
SUDOC|252806816
|
|
996
|
|
|
‡2
LC|n 2005177549
|
|
996
|
|
|
‡2
ISNI|0000000497741891
|
|
996
|
|
|
‡2
PTBNP|1089437
|
|
996
|
|
|
‡2
ISNI|0000000036954464
|
|
996
|
|
|
‡2
BLBNB|000555905
|
|
996
|
|
|
‡2
PTBNP|39634
|
|
996
|
|
|
‡2
PLWABN|9810631781605606
|
|
996
|
|
|
‡2
PTBNP|219840
|
|
996
|
|
|
‡2
ISNI|0000000383791727
|
|
996
|
|
|
‡2
ISNI|0000000069622781
|
|
996
|
|
|
‡2
PTBNP|944142
|
|
996
|
|
|
‡2
PTBNP|1322084
|
|
996
|
|
|
‡2
BLBNB|000619187
|
|
996
|
|
|
‡2
PTBNP|103802
|
|
996
|
|
|
‡2
ISNI|0000000032173038
|
|
996
|
|
|
‡2
DNB|1056479523
|
|
996
|
|
|
‡2
LC|n 2020183864
|
|
996
|
|
|
‡2
PTBNP|287716
|
|
996
|
|
|
‡2
ISNI|0000000073303265
|
|
996
|
|
|
‡2
LC|n 95921100
|
|
996
|
|
|
‡2
LC|nr 99040404
|
|
996
|
|
|
‡2
DNB|1060695839
|
|
996
|
|
|
‡2
LC|n 2024250511
|
|
996
|
|
|
‡2
BLBNB|000461064
|
|
996
|
|
|
‡2
PTBNP|1360482
|
|
996
|
|
|
‡2
ISNI|0000000069787973
|
|
996
|
|
|
‡2
ISNI|0000000390487950
|
|
996
|
|
|
‡2
BLBNB|000309896
|
|
996
|
|
|
‡2
DNB|1057143510
|
|
996
|
|
|
‡2
ISNI|0000000408636978
|
|
996
|
|
|
‡2
PTBNP|1224188
|
|
996
|
|
|
‡2
BLBNB|000164419
|
|
996
|
|
|
‡2
ISNI|0000000000272883
|
|
996
|
|
|
‡2
DNB|136196985
|
|
996
|
|
|
‡2
ISNI|0000000495698105
|
|
996
|
|
|
‡2
LC|n 2015210827
|
|
996
|
|
|
‡2
BLBNB|001474919
|
|
996
|
|
|
‡2
PTBNP|210461
|
|
996
|
|
|
‡2
DNB|1032887001
|
|
996
|
|
|
‡2
SUDOC|108060403
|
|
996
|
|
|
‡2
PTBNP|1705322
|
|
996
|
|
|
‡2
ISNI|000000007041260X
|
|
996
|
|
|
‡2
DNB|1317207971
|
|
996
|
|
|
‡2
CAOONL|ncf11415285
|
|
996
|
|
|
‡2
DNB|1135996792
|
|
996
|
|
|
‡2
LC|n 2016257435
|
|
996
|
|
|
‡2
PTBNP|42945
|
|
996
|
|
|
‡2
BLBNB|000295138
|
|
996
|
|
|
‡2
LC|n 2021053962
|
|
996
|
|
|
‡2
LC|nb2012025627
|
|
996
|
|
|
‡2
ISNI|0000000069293623
|
|
996
|
|
|
‡2
SUDOC|06891279X
|
|
996
|
|
|
‡2
BLBNB|000525076
|
|
996
|
|
|
‡2
RERO|A005851856
|
|
996
|
|
|
‡2
BNF|12125478
|
|
996
|
|
|
‡2
PTBNP|60053
|
|
996
|
|
|
‡2
BLBNB|000187499
|
|
996
|
|
|
‡2
PTBNP|30908
|
|
996
|
|
|
‡2
DNB|1056356928
|
|
996
|
|
|
‡2
ISNI|000000006789373X
|
|
996
|
|
|
‡2
ISNI|0000000068211171
|
|
996
|
|
|
‡2
N6I|vtls000325045
|
|
996
|
|
|
‡2
PTBNP|1460780
|
|
996
|
|
|
‡2
LC|n 2005089497
|
|
996
|
|
|
‡2
ISNI|0000000069220061
|
|
996
|
|
|
‡2
BLBNB|000257323
|
|
996
|
|
|
‡2
ISNI|0000000070229549
|
|
996
|
|
|
‡2
PTBNP|1402761
|
|
996
|
|
|
‡2
BNF|12073362
|
|
996
|
|
|
‡2
ISNI|0000000068411122
|
|
996
|
|
|
‡2
PTBNP|60049
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
